Ikbkgtm1a(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Ikbkgtm1a(EUCOMM)Wtsi |
| Name: |
inhibitor of kappaB kinase gamma; targeted mutation 1a, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4432136 |
| Gene: |
Ikbkg Location: ChrX:73436896-73497460 bp, + strand Genetic Position: ChrX, 38.0 cM
|
| IMPC: |
Ikbkg gene page |
|
| Mutant Cell Lines: |
EPD0102_2_A04, EPD0102_2_B04, EPD0102_2_B05, EPD0102_2_C05, EPD0102_2_D04, EPD0102_2_E04, EPD0102_2_E05, EPD0102_2_G04 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8.F6 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Conditional ready, Null/knockout, Reporter) |
| Mutation: |
|
Insertion
Vector: L1L2_gt1
|
| |
|
Mutation details: The L1L2_gt1 cassette was inserted at position 73476985 of Chromosome X upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT flanked lacZ/neomycin sequence followed by a loxP site. An additional loxP site is inserted downstream of the targeted exon(s) at position 73477880. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele can be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. If cre expression occurs without flp expression, a reporter knockout mouse will be created. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:155845, J:173534)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ikbkg Mutation: |
16 strains or lines available
|
|
| Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
| All: |
2 reference(s) |
|